Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Multiple Sclerosis

  Free Subscription


1 AJNR Am J Neuroradiol
1 Am J Hum Genet
1 Arch Phys Med Rehabil
1 J Immunol
1 J Neurol
1 J Neurol Neurosurg Psychiatry
1 J Neurosci
1 Lancet Neurol
8 Mult Scler
1 Nervenarzt
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol (Paris)

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    AJNR Am J Neuroradiol

  1. HAGIWARA A, Hori M, Yokoyama K, Nakazawa M, et al
    Analysis of White Matter Damage in Patients with Multiple Sclerosis via a Novel In Vivo MR Method for Measuring Myelin, Axons, and G-Ratio.
    AJNR Am J Neuroradiol. 2017 Aug 3. doi: 10.3174/ajnr.A5312.
    PubMed     Text format     Abstract available

    Am J Hum Genet

  2. MANOUSAKI D, Dudding T, Haworth S, Hsu YH, et al
    Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis.
    Am J Hum Genet. 2017;101:227-238.
    PubMed     Text format     Abstract available

    Arch Phys Med Rehabil

  3. BATTALIO SL, Silverman AM, Ehde DM, Amtmann D, et al
    Resilience and function in adults with physical disabilities: an observational study.
    Arch Phys Med Rehabil. 2016 Dec 16. pii: S0003-9993(16)31306.
    PubMed     Text format     Abstract available

    J Immunol

  4. AGGELAKOPOULOU M, Kourepini E, Paschalidis N, Panoutsakopoulou V, et al
    ERbeta in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
    J Immunol. 2016 May 13. pii: 1600246.
    PubMed     Text format     Abstract available

    J Neurol

  5. EICHINGER P, Wiestler H, Zhang H, Biberacher V, et al
    A novel imaging technique for better detecting new lesions in multiple sclerosis.
    J Neurol. 2017 Jul 29. doi: 10.1007/s00415-017-8576.
    PubMed     Text format     Abstract available

    J Neurol Neurosurg Psychiatry

  6. CLAFLIN SB, van der Mei IAF, Taylor BV
    Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016.
    J Neurol Neurosurg Psychiatry. 2017 Aug 2. pii: jnnp-2016-314490.
    PubMed     Text format     Abstract available

    J Neurosci

  7. MANDOLESI G, De Vito F, Musella A, Gentile A, et al
    miR-142-3p Is a Key Regulator of IL-1beta-Dependent Synaptopathy in Neuroinflammation.
    J Neurosci. 2017;37:546-561.
    PubMed     Text format     Abstract available

    Lancet Neurol

  8. SIHVONEN AJ, Sarkamo T, Leo V, Tervaniemi M, et al
    Music-based interventions in neurological rehabilitation.
    Lancet Neurol. 2017;16:648-660.
    PubMed     Text format     Abstract available

    Mult Scler

    Why non-inferiority is more challenging than superiority?
    Mult Scler. 2017;23:790-791.
    PubMed     Text format     Abstract available

  10. HOEPNER R, Kolb EM, Dahlhaus S, Hellwig K, et al
    Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.
    Mult Scler. 2017;23:830-835.
    PubMed     Text format     Abstract available

  11. PITTERI M, Romualdi C, Magliozzi R, Monaco S, et al
    Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study.
    Mult Scler. 2017;23:848-854.
    PubMed     Text format     Abstract available

  12. BALDASSARI LE, Salter AR, Longbrake EE, Cross AH, et al
    Streamlined EDSS for use in multiple sclerosis clinical practice: Development and cross-sectional comparison to EDSS.
    Mult Scler. 2017 Jul 1:1352458517721357. doi: 10.1177/1352458517721357.
    PubMed     Text format     Abstract available

  13. CANCELLI A, Cottone C, Giordani A, Migliore S, et al
    Personalized, bilateral whole-body somatosensory cortex stimulation to relieve fatigue in multiple sclerosis.
    Mult Scler. 2017 Jul 1:1352458517720528. doi: 10.1177/1352458517720528.
    PubMed     Text format     Abstract available

  14. DUNN N, Juto A, Ryner M, Manouchehrinia A, et al
    Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies.
    Mult Scler. 2017 Jul 1:1352458517720044. doi: 10.1177/1352458517720044.
    PubMed     Text format     Abstract available

  15. RUHRMANN S, Ewing E, Piket E, Kular L, et al
    Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes.
    Mult Scler. 2017 Aug 1:1352458517721356. doi: 10.1177/1352458517721356.
    PubMed     Text format     Abstract available

  16. VERMOHLEN V, Schiller P, Schickendantz S, Drache M, et al
    Hippotherapy for patients with multiple sclerosis: A multicenter randomized controlled trial (MS-HIPPO).
    Mult Scler. 2017 Aug 1:1352458517721354. doi: 10.1177/1352458517721354.
    PubMed     Text format     Abstract available


  17. ZIEMSSEN T, Rothenbacher D, Kuhle J, Berger T, et al
    [Real-world evidence : Benefits and limitations in multiple sclerosis research].
    Nervenarzt. 2017 Aug 3. doi: 10.1007/s00115-017-0387.
    PubMed     Text format     Abstract available

    PLoS One

  18. MESSINA S, Solaro C, Righini I, Bergamaschi R, et al
    Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
    PLoS One. 2017;12:e0180651.
    PubMed     Text format     Abstract available

  19. WURTH S, Kuenz B, Bsteh G, Ehling R, et al
    Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
    PLoS One. 2017;12:e0182462.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  20. GUGLIELMETTI C, Najac C, Didonna A, Van der Linden A, et al
    Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model.
    Proc Natl Acad Sci U S A. 2017 Jul 31. pii: 201613345.
    PubMed     Text format     Abstract available

    Rev Neurol (Paris)

    Should we broaden indications for anti-JCV antibody tests in multiple sclerosis patients? YES.
    Rev Neurol (Paris). 2017 Jul 28. pii: S0035-3787(17)30648.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.